TITLE:
Historical Evolution of Fluid Therapy and Contemporary Challenges: From Intravenous Injection to Artificial Blood
AUTHORS:
Michiaki Yamakage
KEYWORDS:
Fluid Therapy, Blood Transfusion, Plasma Substitutes, Ringer’s Solution, Enhanced Recovery After Surgery (ERAS), Perioperative Management, Artificial Blood
JOURNAL NAME:
Open Journal of Anesthesiology,
Vol.15 No.12,
December
24,
2025
ABSTRACT: Fluid therapy has evolved dramatically from its origins in 17th-century blood transfusion experiments to sophisticated, modern, perioperative fluid management protocols. This comprehensive review traces the historical development of intravenous fluid administration, beginning with William Harvey’s circulation theory and Christopher Wren’s pioneering venous injections, through the cholera epidemics that necessitated early fluid replacement therapy, to Sydney Ringer’s groundbreaking electrolyte solutions. The evolution of blood transfusion from dangerous animal-to-human experiments to safe ABO-compatible transfusions paralleled the development of plasma substitutes and colloid solutions. Pediatric fluid therapy emerged as a specialized field in the early 20th century, with contributions from researchers like James Gamble and Daniel Darrow establishing the fundamental principles of water and electrolyte balance. Modern perioperative fluid management has been revolutionized by Enhanced Recovery After Surgery (ERAS) protocols, goal-directed fluid therapy, and evidence-based approaches that optimize patient outcomes. Contemporary challenges include the ongoing debate over crystalloid versus colloid solutions, the safety concerns surrounding hydroxyethyl starch preparations, and the continued quest for effective artificial blood substitutes. Recent advances in artificial oxygen carriers, particularly Professor Hiromi Sakai’s hemoglobin vesicles (HbV) developed through three decades of research at Nara Medical University, have demonstrated promising Phase 1 trial results with acceptable safety profiles, offering potential solutions to blood supply shortages and compatibility issues with anticipated clinical implementation by 2030. This historical perspective illuminates how empirical observations evolved into evidence-based practice, while highlighting persistent challenges in optimizing fluid therapy for diverse clinical scenarios.